Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:35 2024-05-03 am EDT			5-day change	1st Jan Change
850.6 ^DKK	-2.58%		-4.06%	+21.85%

May. 03	News Highlights : Top Company News of the Day - Friday at 5 PM ET	DJ
May. 03	News Highlights : Top Company News of the Day - Friday at 7 PM ET	DJ

NOVO NORDISK : Gets a Sell rating from Jefferies

July 16, 2020 at 04:23 am EDT

Jefferies reiterate its Sell rating. The target price has been revised upwards and is now set at DKK 330, compared with DKK 310 previously.

Latest news about Novo Nordisk A/S

News Highlights : Top Company News of the Day - Friday at 5 PM ET	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 7 PM ET	May. 03	DJ
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 3 PM ET	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 1 PM ET	May. 03	DJ
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	May. 03	MT
Novo Nordisk: share price falls, analyst adjusts target	May. 03	CF
Catalent, Novo Nordisk Antitrust Review Extended by FTC	May. 03	MT
News Highlights : Top Company News of the Day - Friday at 11 AM ET	May. 03	DJ
NOVO NORDISK : DZ Bank sticks Neutral	May. 03	ZD
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	May. 03	DJ
News Highlights : Top Company News of the Day - Friday at 9 AM ET	May. 03	DJ
NOVO NORDISK : Stifel lowers target slightly	May. 03	CF
US FTC seeks more information on Novo Nordisk parent-Catalent deal	May. 03	RE
FTC seeks more information on Novo Holdings-Catalent deal	May. 03	RE
Transcript : Novo Nordisk A/S, Q1 2024 Earnings Call, May 03, 2024	May. 03
NOVO NORDISK : Buy rating from Deutsche Bank	May. 03	ZD
News Highlights : Top Company News of the Day - Friday at 7 AM ET	May. 03	DJ
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
Amgen shares jump after teasing weight-loss drug data, rivals slip	May. 03	RE
GSK plc : Back on track	May. 03
NOVO NORDISK : JP Morgan gives a Buy rating	May. 03	ZD
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	May. 02	DJ
Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK	May. 02	MT
Sector Update: Health Care Stocks Softer Late Afternoon	May. 02	MT

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Novo Nordisk CEO: Demand for Wegovy outstrips supply

May 02, 2024 at 12:36 pm EDT

NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions

May 02, 2024 at 12:09 pm EDT

Novo Nordisk doesn't disappoint

January 31, 2024 at 10:48 am EST

More Strategies

Ratings for Novo Nordisk A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

850.6 DKK

Average target price

908.4 DKK

Spread / Average Target

+6.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
AMGEN INC.	+8.08%	167B
PFIZER, INC.	-3.40%	157B
SANOFI	+1.72%	123B

Other Pharmaceuticals

Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

NOVO NORDISK : Gets a Sell rating from Jefferies

Latest news about Novo Nordisk A/S

Chart Novo Nordisk A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Novo Nordisk A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals